OrisDX Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4M

  • Investors
  • 9

OrisDX General Information

Description

Developer of a novel non-invasive salivary diagnostic test designed to check oral cavity pre-malignancies and cancers. The company's product utilizes biomarker-based molecular genomic techniques to diagnose oral cavity cancers, enabling healthcare professionals to perform early diagnosis through non-invasive genetic testing of their saliva.

Contact Information

Website
www.orisdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 363 East Wacker Drive
  • Unit 2703
  • Chicago, IL 60601
  • United States
+1 (630)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Oncology
Corporate Office
  • 363 East Wacker Drive
  • Unit 2703
  • Chicago, IL 60601
  • United States
+1 (630)

OrisDX Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrisDX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 23-May-2025 $4M Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2024 Completed Product Development
4. Accelerator/Incubator 07-Jun-2022 Completed Product Development
3. Accelerator/Incubator 11-May-2022 Completed Product Development
2. Accelerator/Incubator 10-May-2022 $10K $10K Completed Product Development
1. University Spin-Out 08-Apr-2022 Completed Product Development
To view OrisDX’s complete valuation and funding history, request access »

OrisDX Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view OrisDX’s complete cap table history, request access »

OrisDX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrisDX Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Physicians Fund Angel Group Minority
MFV Partners Venture Capital Minority
OCA Ventures Venture Capital Minority
Revere Partners Venture Capital Minority
UCM Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

OrisDX FAQs

  • When was OrisDX founded?

    OrisDX was founded in 2022.

  • Where is OrisDX headquartered?

    OrisDX is headquartered in Chicago, IL.

  • What is the size of OrisDX?

    OrisDX has 9 total employees.

  • What industry is OrisDX in?

    OrisDX’s primary industry is Diagnostic Equipment.

  • Is OrisDX a private or public company?

    OrisDX is a Private company.

  • What is the current valuation of OrisDX?

    The current valuation of OrisDX is .

  • What is OrisDX’s current revenue?

    The current revenue for OrisDX is .

  • How much funding has OrisDX raised over time?

    OrisDX has raised $4.92M.

  • Who are OrisDX’s investors?

    Angel Physicians Fund, MFV Partners, OCA Ventures, Revere Partners, and UCM Ventures are 5 of 9 investors who have invested in OrisDX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process